Connect with us

Meet Premchand Godha CA who took over sAtruggling IPCA Laboratories together with Amitabh Bachchan

Trending

Meet Premchand Godha CA who took over sAtruggling IPCA Laboratories together with Amitabh Bachchan

Meet Premchand Godha CA who took over sAtruggling IPCA Laboratories together with Amitabh Bachchan

Meet Premchand Godha CA
who took over sAtruggling IPCA Laboratories together with Amitabh Bachchan

Premchand Godha had apparently served as a CA for Amitabh Bachchan before collaborating with the superstar’s family to emerge as a businessman.

In 1975, he became Bachchan and his family’s business partner as they together acquired a struggling IPCA
Laboratory founded by an Englishman in 1949. IPCA Z Laboratories, is today a leading pharma manufacturer with a market cap of over Rs 28,000 crore.

Coming from a family of farmers, Premchand Godha has as of today emerged one of the richest persons in India.

He chairs the $711 million revenue company Ipca Labs manufacturers of bulk drugs, drug intermediates and drug formulations. T

The firm is also a leader in drugs for diabetes, anti-malarial, pain management and cardio-vascular treatments.

Hailing from Rajasthan, Godha graduated in commerce from the University of Rajasthan.

He then became a certified Chartered Accountant from the Institute of Chartered Accountants of India. G

Godha had apparently served as a CA for Amitabh Bachchan before collaborating with the superstar’s family to buy Ipca. This also included Jaya Bachchan.

Amitabh Bachchan’s brother Ajitabh Bachchan had served as chairperson of Godha’s company in 90’s.

When the Bachchan family hit tough financial times around 1999, they sold their stake in the company and ended the association.

Under the current management led by Godha, Ipca has seen its turnover rise from just Rs 54 lakh to a whopping Rs 4,422 crore. 71-year-old Premchand Godha is a billionaire with net worth over Rs 10,800 crore ($1.3 billion).

News Edit K.V.Raman

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in Trending

To Top